Applied Therapeutics (APLT)

• Market cap: $16.9M
• 1 day: -0.26%
• 5 days: -46.84%
• 1 month: -58.83%
• 3 months: -71.88%
• 6 months: -68.4%
• Year to date: -86.97%
• 1 year: -89.83%
• 5 years: -99.51%
• 10 years: -98.76%
• Sector: Healthcare
• Industry: Biotechnology

About: Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Employees: 28